Dr. Edward G. Taylor joins ABIOMED to lead artificial heart program.DANVERS, Mass.--(BUSINESS WIRE)--Oct. 31, 1996-- ABIOMED, Inc. (pronounced "AB-EE-O-MED"), (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on - ABMD) today announced that Dr. Edward G. Taylor has joined ABIOMED as a Divisional Vice President and has been appointed Director of the Company's Total Artificial Heart Program, effective on December 1, 1996. Dr. Taylor, age 45, comes to ABIOMED from the U.S. Air Force where he attained the rank of Colonel and was most recently the Program Director for the nation's Airborne Warning And Control System The Airborne Warning and Control System (AWACS) is an aircraft system designed to carry out surveillance, and C2BM (command and control, battle management) functions. (AWACS AWACS (Airborne Warning and Control System) Mobile, long-range radar surveillance-and-control centre for air defense. Used by the U.S. Air Force since 1977, AWACS is mounted in a specially modified Boeing 707 aircraft, with its main radar antenna affixed to a rotating dome. ). Previously, he had directed high technology research and development of nationally significant defense programs, including the management of small (30 people) and large (650 people) teams focused on performance and on-time execution of budget-sensitive programs. Upon joining ABIOMED, Dr. Taylor remarked: "I am pleased and honored to be associated with the Total Artificial Heart Program. It is an exciting project entering a dynamic phase. The technology is as cutting edge as any of the satellite and avionics programs that I have been involved in, and tangible results are clearly within sight. I am fully conscious of the national significance and imperative of the program and I look forward to the challenge." "Dr. Taylor brings to ABIOMED 24 years of relevant experience, including the design and manufacture of new age technology with particular emphasis on ultra high reliability applications with life critical functionality," said Dr. David M. Lederman, President and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. of ABIOMED. "He is a tremendous addition to our management team as we prepare to transition our artificial heart technology from the laboratory into pre-clinical validation, production and clinical trials." Dr. Taylor holds a Bachelor's degree from the Illinois Institute of Technology Illinois Institute of Technology, in Chicago; coeducational; founded 1940 by a merger of Armour Institute of Technology (founded 1892) and Lewis Institute (1896). , a Master's degree from the Air Force Institute of Technology The Naval Postgraduate School serves a similar purpose for the U.S. Navy and U.S. Marine Corps. The U.S. Army does not have a comparable school; Army officers study at the Naval Postgraduate School or AFIT. and a Ph.D. degree in Aeronautics and Astronautics from the Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, . He and his wife, Susan Fennelly, are the parents of 2 boys. Based in Danvers, Massachusetts, ABIOMED, Inc. develops, manufactures and markets innovative cardiovascular, medical and dental products and is a leader in the research and development of advanced artificial heart systems. CONTACT: ABIOMED John F. Thero or Kristin T. Hurley (508) 777-5410 Ext. 622 e-mail: abmd@abiomed.com Visit our web site at http://www.abiomed.com |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion